Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Respir Med ; 217: 107364, 2023 10.
Article in English | MEDLINE | ID: mdl-37474077

ABSTRACT

INTRODUCTION: Current guidelines incorporate the option of a rapid onset bronchodilator (ROB) plus an inhaled corticosteroid (ICS) for the relief of asthma symptoms, but there is doubt whether the combined therapy for relief could lead to suboptimal maintenance therapy since individuals might prefer it to the maintenance therapy. The objective of this study was to assess whether the type of rescue medication that the individual with asthma has available is associated with suboptimal maintenance therapy. METHODS: This cross-sectional study included non-smokers with asthma, ≥12 years old. The individuals attended an appointment with a physician, responded questionnaires and performed a spirometry. Adjusted regression analysis evaluated whether the type of rescue medication was associated with suboptimal maintenance therapy. RESULTS: We enrolled 953 individuals, of which 221 reported having no rescue medication, 171 carried any ROB + ICS for symptoms relief and 561 carried SABA alone to rescue. The frequency of suboptimal maintenance therapy was not different between individuals carrying the combination and those carrying SABA alone for symptoms relief, but individuals who reported having no rescue medication had less suboptimal maintenance therapy (P < 0.01). CONCLUSIONS: The frequency of suboptimal maintenance therapy for asthma was similar between individuals carrying any ROB + ICS for symptoms relief and those carrying SABA alone to rescue, whilst it was less frequent in the group that reported not having any reliever medication. Data from this study indicate that recent changes in asthma guidelines regarding the use of rescue medication have little risk of impairing maintenance therapy.


Subject(s)
Anti-Asthmatic Agents , Asthma , Humans , Child , Anti-Asthmatic Agents/therapeutic use , Cross-Sectional Studies , Asthma/drug therapy , Bronchodilator Agents/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Administration, Inhalation , Formoterol Fumarate/therapeutic use , Budesonide/therapeutic use , Ethanolamines/therapeutic use
2.
Med Mycol ; 59(8): 773-783, 2021 Jul 14.
Article in English | MEDLINE | ID: mdl-33550419

ABSTRACT

We aimed to investigate the effects of ethanol and its metabolites (ß-hydroxybutyrate and sodium acetate) in the effector functions of macrophages in response to Paracoccidioides brasiliensis yeast cells and to determine their influence in the development of the adaptive response. Purified peripheral blood monocytes were differentiated into macrophages and were treated with ethanol, ß-hydroxybutyrate, and sodium acetate, and stimulated with P. brasiliensis yeast cells and evaluated for their phenotypic characteristics, functional activity, and capability to induce T cells activation/differentiation. We found that the ethanol treatment diminished the expression of HLA-AB, HLA-DR, CD80, and CD86, modulating the expression of dectin-1, as well as Syk phosphorylation. The ethanol treatment increased the phagocytic activity, expression of CD206, and IL-10 production; however, reduced ROS production, fungicidal activity, caspase-1 cleavage, and IL-1ß and IL-6 production. Our data also showed that the presence of ethanol reduced the differentiation of Th1 and Th17 cells and increased the frequency of Th2 cells. Our results indicated that ethanol exposure could suppress effector function of macrophages, possibly leading to the polarization of M2 macrophages. The ethanol modulates the expression of costimulatory and antigen-presentation molecules and interferes with the NLRP3 inflammasome. Altogether, these alterations affect the development of the adaptive response, decreasing the frequency of IL-17, IL-22, and IFN- γ producing cells, and increasing the frequency of IL-4 producing cells. Therefore, exposure to ethanol can impair the capability of macrophages to exert their effector functions and activate the acquired response related to resistance to P. brasiliensis infection.


Subject(s)
Ethanol/pharmacology , Macrophages/drug effects , Macrophages/microbiology , Paracoccidioides/physiology , Paracoccidioidomycosis/immunology , Adaptive Immunity/drug effects , Antifungal Agents/pharmacology , CD3 Complex/analysis , Caspase 1/analysis , Cytokines/analysis , Cytokines/drug effects , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Inflammasomes/drug effects , Inflammasomes/metabolism , Lipopolysaccharide Receptors/analysis , Macrophages/immunology , NLR Family, Pyrin Domain-Containing 3 Protein/drug effects , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Peroxides/metabolism , Phagocytosis/drug effects
3.
Rev Soc Bras Med Trop ; 45(2): 225-31, 2012.
Article in English | MEDLINE | ID: mdl-22534997

ABSTRACT

INTRODUCTION: This study aimed to isolate and identify Candida spp. from the environment, health practitioners, and patients with the presumptive diagnosis of candidiasis in the Pediatric Unit at the Universitary Hospital of the Jundiaí Medical College, to verify the production of enzymes regarded as virulence factors, and to determine how susceptible the isolated samples from patients with candidiasis are to antifungal agents. METHODS: Between March and November of 2008 a total of 283 samples were taken randomly from the environment and from the hands of health staff, and samples of all the suspected cases of Candida spp. hospital-acquired infection were collected and selected by the Infection Control Committee. The material was processed and the yeast genus Candida was isolated and identified by physiological, microscopic, and macroscopic attributes. RESULTS: The incidence of Candida spp. in the environment and employees was 19.2%. The most frequent species were C. parapsilosis and C. tropicalis among the workers, C. guilliermondii and C. tropicalis in the air, C. lusitanae on the contact surfaces, and C. tropicalis and C. guilliermondii in the climate control equipment. The college hospital had 320 admissions, of which 13 (4%) presented Candida spp. infections; three of them died, two being victims of a C. tropicalis infection and the remaining one of C. albicans. All the Candida spp. in the isolates evidenced sensitivity to amphotericin B, nystatin, and fluconazole. CONCLUSIONS: The increase in the rate of hospital-acquired infections caused by Candida spp. indicates the need to take larger measures regarding recurrent control of the environment.


Subject(s)
Candida/isolation & purification , Candidiasis/microbiology , Cross Infection/microbiology , Hand/microbiology , Inpatients , Personnel, Hospital , Antifungal Agents/pharmacology , Candida/classification , Candida/drug effects , Hospitals, University , Humans , Incidence , Intensive Care Units, Pediatric , Microbial Sensitivity Tests
4.
Rev. Soc. Bras. Med. Trop ; 45(2): 225-231, Mar.-Apr. 2012. tab
Article in English | LILACS | ID: lil-625181

ABSTRACT

INTRODUCTION: This study aimed to isolate and identify Candida spp. from the environment, health practitioners, and patients with the presumptive diagnosis of candidiasis in the Pediatric Unit at the Universitary Hospital of the Jundiaí Medical College, to verify the production of enzymes regarded as virulence factors, and to determine how susceptible the isolated samples from patients with candidiasis are to antifungal agents. METHODS: Between March and November of 2008 a total of 283 samples were taken randomly from the environment and from the hands of health staff, and samples of all the suspected cases of Candida spp. hospital-acquired infection were collected and selected by the Infection Control Committee. The material was processed and the yeast genus Candida was isolated and identified by physiological, microscopic, and macroscopic attributes. RESULTS: The incidence of Candida spp. in the environment and employees was 19.2%. The most frequent species were C. parapsilosis and C. tropicalis among the workers, C. guilliermondii and C. tropicalis in the air, C. lusitanae on the contact surfaces, and C. tropicalis and C. guilliermondii in the climate control equipment. The college hospital had 320 admissions, of which 13 (4%) presented Candida spp. infections; three of them died, two being victims of a C. tropicalis infection and the remaining one of C. albicans. All the Candida spp. in the isolates evidenced sensitivity to amphotericin B, nystatin, and fluconazole. CONCLUSIONS: The increase in the rate of hospital-acquired infections caused by Candida spp. indicates the need to take larger measures regarding recurrent control of the environment.


INTRODUÇÃO: Isolar e identificar Candida spp. do ambiente, dos profissionais de saúde e de pacientes com diagnóstico presuntivo de candidíase, em Unidade de Pediatria do Hospital Universitário da Faculdade de Medicina de Jundiaí, verificar a produção de enzimas consideradas fatores de virulência e identificar a resistência das cepas isoladas dos pacientes aos antifúngicos. MÉTODOS: Foram feitas 283 coletas no período entre março e novembro de 2008 de forma randomizada do ambiente, das mãos de profissionais de saúde e de todos os pacientes com casos suspeitos de infecção hospitalar por Candida spp., triados pelo Comitê de Infecção Hospitalar. Todo o material coletado foi processado e as leveduras do gênero Candida foram isoladas e identificadas pelas características macroscópicas, microscópicas e fisiológicas. RESULTADOS: A incidência de Candida spp. no meio-ambiente e funcionários foi de 19,2%. Destes, as espécies mais frequentes entre os funcionários foram C. parapsilosis e C. tropicalis; no ar ambiente, C. guilliermondii e C. tropicalis; nas superfícies dos ambientes, C. lusitanae e nos sistemas de climatização, C. tropicalis e C. guilliermondii. No período de estudo, foram feitas 320 internações, e 13 (4%) apresentaram infecção hospitalar por Candida spp, sendo que 3 pacientes foram a óbito, dois apresentando infecção por C. tropicalis e um por C. albicans. Todas as espécies de Candida spp. isoladas dos pacientes foram sensíveis à anfotericina B, nistatina e fluconazol. CONCLUSÕES: Verificamos um aumento crescente de infecções hospitalares por Candida não albicans, o que sugere a necessidade de maiores precauções em relação a um controle ambiental destas espécies.


Subject(s)
Humans , Candida/isolation & purification , Candidiasis/microbiology , Cross Infection/microbiology , Hand/microbiology , Inpatients , Personnel, Hospital , Antifungal Agents/pharmacology , Candida/classification , Candida/drug effects , Hospitals, University , Incidence , Intensive Care Units, Pediatric , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...